Skip to main content

Table 1 The diagnostic value of miR-26 in diseases in clinical trials

From: The translational potential of miR-26 in atherosclerosis and development of agents for its target genes ACC1/2, COL1A1, CPT1A, FBP1, DGAT2, and SMAD7

Diseases

Status

Refs.

Atherosclerosis

Completed

[36]

HCC

Phase 3

[39]

T1DM

Completed

[50]

T2DM

Completed

[50]

MINOCA

Recruiting

[51]

Leukoencephalopathy

Recruiting

[52]

EHOA and PsA

Completed

[53]

Prostate cancer

Recruiting

[54]

Atopy in children over time

Active, not recruiting

[55]

  1. The information was obtained from ClinicalTrials and Pubmed
  2. HCC hepatocellular carcinoma, EHOA erosive hand osteoarthritis, MINOCA myocardial infarction with nonobstructive coronary arteries, PsA psoriatic arthritis, T1DM type 1 diabetes mellitus
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840